Key management emerges as a delivery risk in automotive software

Tern plc

As vehicle architectures transition toward software-defined platforms, cryptographic key management is becoming an embedded engineering concern rather than a background cybersecurity task. Software capabilities now define product differentiation in the automotive sector, and this shift is placing new demands on how manufacturers secure, update and validate the integrity of vehicle systems over their full lifecycle.

In earlier automotive cycles, security architectures were simpler. Vehicles had a small number of electronic control units, updates were infrequent, and keys or certificates could be handled manually or with limited automation. As manufacturers expanded into more complex platforms, identity provisioning processes evolved separately across engineering, cloud infrastructure and manufacturing lines.

This fragmentation is now surfacing as a structural constraint across large-scale vehicle programmes. Certificates expire unpredictably, sometimes disabling update functions in fleets already in service. Keys injected during manufacturing may not be recognised by cloud services due to misaligned trust models. Firmware from one generation of hardware may not be signed in a way that is compatible with another, even within the same vehicle line.

In the absence of structured key management, engineering teams may need to pause launches or rework production lines to meet compliance.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Tern cuts H1 loss by 60% as portfolio growth and funding strengthen

Tern reduced its first-half loss by 60%, with net asset value improving and further fundraising strengthening the balance sheet. Additional funding has supported Talking Medicines and Device Authority, while continued progress across the portfolio provides further scope for value creation.

AI control of machines creates a new market for device trust

AI is beginning to control physical machines, increasing demand for technology that can verify device identity before those machines are allowed to act.

Peptide drug development expands beyond GLP-1

GLP-1 success is widening interest in peptide drug development, with the next phase focused on proving clinical value across new therapeutic areas.

Tern Plc announces 90% take-up of Open Offer

Tern Plc has received valid acceptances for 50.9 million Open Offer Shares, representing approximately 90% of the shares available. The fully underwritten offer will raise approximately £509,368 before expenses, with admission of the new shares expected on 24 September 2026.

Talking Medicines moves to capture pharma demand for better patient intelligence

Tighter US pharma advertising rules could increase demand for patient intelligence, supporting the relevance of Talking Medicines’ DrugVoice platform.

Tern portfolio company Talking Medicines launches ‘Intent to Prescribe’ DrugVoice application

Talking Medicines has launched a new DrugVoice application combining its Message Resonance Score™ with near-real-time point-of-care data to help pharmaceutical companies assess links between HCP message alignment and prescribing intent.

Search